Literature DB >> 11243405

Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation.

I Kitabayashi1, Y Aikawa, A Yokoyama, F Hosoda, M Nagai, N Kakazu, T Abe, M Ohki.   

Abstract

Histone acetyltransferase p300 functions as a transcriptional co-activator which interacts with a number of transcription factors. Monocytic leukemia zinc finger protein (MOZ) has histone acetyltransferase activity. We report the fusion of the MOZ gene to the p300 gene in acute myeloid leukemia with translocation t(8;22)(p11;q13). FISH and Southern blot analyses showed the rearrangement of the MOZ and p300 genes. We determined the genomic structure of the p300 and the MOZ genes and the breakpoints of the translocation. Analysis of fusion transcripts indicated that the zinc finger and acetyltransferase domains of MOZ are fused to a largely intact p300. These results suggest that MOZ-p300, which has two acetyltransferase domains, could be involved in leukemogenesis through aberrant regulation of histone acetylation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11243405     DOI: 10.1038/sj.leu.2401983

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  48 in total

1.  Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.

Authors:  I Kitabayashi; Y Aikawa; L A Nguyen; A Yokoyama; M Ohki
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

2.  Molecular requirements for gene expression mediated by targeted histone acetyltransferases.

Authors:  Sandra Jacobson; Lorraine Pillus
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 3.  Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation.

Authors:  Gerald V Denis
Journal:  Discov Med       Date:  2010-12       Impact factor: 2.970

4.  Trisomy 22 as the sole karyotypic abnormality in myelodysplastic syndrome.

Authors:  Tohru Takahashi; Sayaka Harada; Mariko Oki; Mitsuru Yoshimoto; Masayuki Tsujisaki
Journal:  Int J Hematol       Date:  2005-04       Impact factor: 2.490

Review 5.  Chromatin, cancer and drug therapies.

Authors:  Connie C Cortez; Peter A Jones
Journal:  Mutat Res       Date:  2008-07-22       Impact factor: 2.433

6.  PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation.

Authors:  Yutaka Shima; Takito Shima; Tomoki Chiba; Tatsuro Irimura; Pier Paolo Pandolfi; Issay Kitabayashi
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

Review 7.  Protein lysine acetylation by p300/CBP.

Authors:  Beverley M Dancy; Philip A Cole
Journal:  Chem Rev       Date:  2015-01-16       Impact factor: 60.622

Review 8.  The MOZ histone acetyltransferase in epigenetic signaling and disease.

Authors:  Samuel Carlson; Karen C Glass
Journal:  J Cell Physiol       Date:  2014-11       Impact factor: 6.384

9.  Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells.

Authors:  Tim Thomas; Lynn M Corcoran; Raffi Gugasyan; Mathew P Dixon; Thomas Brodnicki; Stephen L Nutt; Donald Metcalf; Anne K Voss
Journal:  Genes Dev       Date:  2006-05-01       Impact factor: 11.361

10.  Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8.

Authors:  Michael R Garbati; Gökçen Alço; Thomas D Gilmore
Journal:  Cancer Lett       Date:  2009-11-30       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.